News

CVS dropped Zepbound in standard coverage. What that means for Zepbound users
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?
MedPage Today4h
Obesity Drug Prices Are Dropping, but Getting a Steady Supply Remains a Challenge
Prices are falling for the popular obesity treatments semaglutide (Wegovy) and tirzepatide (Zepbound), but steady access to the drugs remains challenging. The medications still amount to around $500 ...
Even as prices drop, it's difficult to keep up with demand for new obesity drugs
Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...
Fierce Pharma5h
Novo’s Wegovy retakes top TV spending spot in June, edging out AbbVie, J&J immunology ads
As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. | As summer began and ...
Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Novo Nordisk Teams With WeightWatchers to Expand Wegovy Access
Novo Nordisk A/S (NYSE:NVO) ranks among the best set-it-and-forget-it stocks to buy. Novo Nordisk A/S (NYSE:NVO) announced on ...
Pulmonology Advisor4d
Knockoff Wegovy Concerns End Partnership Between Novo Nordisk and Hims & Hers
Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.
How Novo Nordisk misread the US market for its weight loss sensation
Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...
Novo Nordisk Ignored Internal Warnings On Wegovy Launch Preparedness: Report
Novo Nordisk executives overlooked warnings ahead of Wegovy's launch, leading to supply issues, high costs, and challenges competing with Eli Lilly's Zepbound.